enderView.ai
Sign InStart free
ClosedSuppliesEuropeanOnderhandeling zonder bekendmaking

Voluntary transparency regarding the supply of tetravalent influenza vaccines

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Onderhandeling zonder bekendmaking · 218489
Type
Supplies
33650000
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The National Institute for Public Health and the Environment (RIVM), on behalf of the Ministry of Health, Welfare and Sport (VWS), requests the urgent supply of additional tetravalent influenza vaccines. The increased demand for influenza vaccination is a result of the COVID-19 epidemic, due to which the RIVM requires an additional stock to support the national immunization campaign. The procurement is a supply contract without public notice, involving negotiations with selected suppliers. The emphasis is on rapid delivery, high quality, compliance with EU standards, and a competitive price. Suppliers must demonstrate that they possess the necessary production capacity, certifications, and logistical capabilities to meet the requested volumes within the specified timeframe.

Supplies · Onderhandeling zonder bekendmaking · European procedure

European
Contracting authority
Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
Single contract
Main CPV code
33650000
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderinfluenza vaccinetetravalentsupply

01What is being requested

The National Institute for Public Health and the Environment (RIVM), on behalf of the Ministry of Health, Welfare and Sport (VWS), requests the urgent supply of additional tetravalent influenza vaccines. The increased demand for influenza vaccination is a result of the COVID-19 epidemic, due to which the RIVM requires an additional stock to support the national immunization campaign. The procurement is a supply contract without public notice, involving negotiations with selected suppliers. The emphasis is on rapid delivery, high quality, compliance with EU standards, and a competitive price. Suppliers must demonstrate that they possess the necessary production capacity, certifications, and logistical capabilities to meet the requested volumes within the specified timeframe.

The urgent procurement on behalf of VWS of additional influenza vaccines because the demand for influenza vaccines has increased significantly due to the corona epidemic.

33650000Supplies

02Outcome

Awarded

Europort Pharmaceuticals

03Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

05Bidders in this segment

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME796×
2Siemens Healthineers Nederland B.V.SME7813×
3Mediost B.V.SME7614×
4Philips Nederland B.V.SME7515×
5Bilthoven Biologicals B.V.SME723×
6Genzyme Europe B.VSME723×

06Legal themes that may be relevant here

07Frequently asked questions

What is the purpose of this contract?
The contract concerns the urgent procurement of additional tetravalent influenza vaccines on behalf of the Ministry of Health, Welfare and Sport (VWS).
Why is an additional stock of influenza vaccines needed?
The demand for influenza vaccination has increased significantly as a result of the corona epidemic.

Automatically compiled from the official tender data and documents.

08Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528